SCHEMBL29617656

SCHEMBL29617656

O=C(O)c1cc(-c2ccc(-c3ccc(F)cc3)cc2)nc2ccc(Cl)cc12

nearest known ligand 0.97

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 9/20 0.97
ALDH1A1 P00352 2/20 0.86
HIF1A Q16665 2/20 0.86
HSD17B10 Q99714 2/20 0.86
PTGES O14684 1/20 0.86
ALOX5 P09917 1/20 0.86
CYP2C9 P11712 1/20 0.86
HPGD P15428 1/20 0.86
CASP7 P55210 1/20 0.86
GAA P10253 1/20 0.64
KDM4E B2RXH2 1/20 0.62
KMT2A Q03164 2/20 0.61
MEN1 O00255 1/20 0.60
PLA2G2A P14555 1/20 0.59
MAPT P10636 1/20 0.57
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C19 P33261 1/20 0.56
EPRS1 P07814 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23590305 1.00 DHODH (0.97) DHODHALDH1A1HIF1AHSD17B10PTGES
SCHEMBL14286200 0.93 HSD17B10 (1.00) DHODHALDH1A1HIF1AHSD17B10PTGES
SCHEMBL6186359 0.90 DHODH (0.85) DHODHALDH1A1HIF1AHSD17B10PTGES
SCHEMBL5529524 0.90 HSD17B10 (0.94) DHODHALDH1A1HIF1AHSD17B10PTGES
SCHEMBL26073753 0.89 DHODH (0.89) DHODHALDH1A1HIF1AHSD17B10PTGES
SCHEMBL9788828 0.87 DHODH (0.86) DHODHALDH1A1HIF1AHSD17B10PTGES
SCHEMBL1898306 0.86 HSD17B10 (0.86) DHODHALDH1A1HIF1AHSD17B10PTGES
SCHEMBL19475331 0.85 ALDH1A1 (0.84) DHODHALDH1A1HIF1AHSD17B10PTGES
SCHEMBL8231321 0.85 DHODH (1.00) DHODHALDH1A1HIF1AHSD17B10PTGES
SCHEMBL117422 0.85 PTGES (0.84) DHODHALDH1A1HIF1AHSD17B10PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240294477-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE OHIO STATE INNOVATION FOUNDATION (US) 2024-09-05 US disclosed
US-11999697-B2 Methods and compositions for inhibition of dihydroorotate dehydrogenase OHIO STATE INNOVATION FOUNDATION (US) 2024-06-04 US disclosed
US-11312686-B2 Methods and compositions for inhibition of dihydroorotate dehydrogenase OHIO STATE INNOVATION FOUNDATION (US) 2022-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11312686-B2 Methods and compositions for inhibition of dihydroorotate dehydrogenase DHODH, DLD, DPYD DHODH 1/4885ALDH1A1 72/4885HIF1A 1644/4885
US-20240294477-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE DHODH, DLD, DPYD DHODH 1/4885ALDH1A1 64/4885HIF1A 1566/4885
US-11999697-B2 Methods and compositions for inhibition of dihydroorotate dehydrogenase DHODH, DLD, DPYD DHODH 1/4885ALDH1A1 64/4885HIF1A 1566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.